Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Importance of Monitoring Primary Hemostasis Pathology in Patients on Extracorporeal Membrane Oxygenation (ECMO) During Lung Transplantation

NCT04456894 is registered in ClinicalTrials.gov with University Hospital, Motol as lead sponsor.

NCT NCT04456894
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04456894 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Importance of Monitoring Primary Hemostasis Pathology in Patients on Extracorporeal Membrane Oxygenation (ECMO) During Lung Transplantation
Lead sponsor
University Hospital, Motol
Phase
Observational
Overall status
Completed
Start date
November 7, 2020
Completion date
August 15, 2023
Enrollment
36 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

ecmo primary hemostasis pathology